These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 28353418)
1. Factors Associated with the Development of Tertiary Peritonitis in Critically Ill Patients. Ballus J; Lopez-Delgado JC; Sabater-Riera J; Perez-Fernandez XL; Betbese AJ; Roncal JA Surg Infect (Larchmt); 2017 Jul; 18(5):588-595. PubMed ID: 28353418 [TBL] [Abstract][Full Text] [Related]
2. Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes. Ballus J; Lopez-Delgado JC; Sabater-Riera J; Perez-Fernandez XL; Betbese AJ; Roncal JA BMC Infect Dis; 2015 Jul; 15():304. PubMed ID: 26223477 [TBL] [Abstract][Full Text] [Related]
3. Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit. Chromik AM; Meiser A; Hölling J; Sülberg D; Daigeler A; Meurer K; Vogelsang H; Seelig MH; Uhl W J Gastrointest Surg; 2009 Jul; 13(7):1358-67. PubMed ID: 19352781 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Barie PS; Hydo LJ; Eachempati SR Surg Infect (Larchmt); 2004; 5(4):365-73. PubMed ID: 15744128 [TBL] [Abstract][Full Text] [Related]
5. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units. Montravers P; Perrigault PF; Timsit JF; Mira JP; Lortholary O; Leroy O; Gangneux JP; Guillemot D; Bensoussan C; Bailly S; Azoulay E; Constantin JM; Dupont H; Clin Microbiol Infect; 2017 Feb; 23(2):117.e1-117.e8. PubMed ID: 27746395 [TBL] [Abstract][Full Text] [Related]
6. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid. Li WS; Lee CH; Liu JW J Microbiol Immunol Infect; 2017 Jun; 50(3):370-376. PubMed ID: 26321461 [TBL] [Abstract][Full Text] [Related]
7. Infections in a surgical intensive care unit of a university hospital in Greece. Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663 [TBL] [Abstract][Full Text] [Related]
8. Tertiary peritonitis: clinical features of a complex nosocomial infection. Nathens AB; Rotstein OD; Marshall JC World J Surg; 1998 Feb; 22(2):158-63. PubMed ID: 9451931 [TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Dupont H; Paugam-Burtz C; Muller-Serieys C; Fierobe L; Chosidow D; Marmuse JP; Mantz J; Desmonts JM Arch Surg; 2002 Dec; 137(12):1341-6; discussion 1347. PubMed ID: 12470095 [TBL] [Abstract][Full Text] [Related]
11. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis. Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553 [TBL] [Abstract][Full Text] [Related]
12. Microbiological profiles and clinical outcomes of critically ill surgical patients with lower gastrointestinal perforation in Japan: a single-center retrospective observational study. Nishikawa T; Ito J; Seo R; Ariyoshi K; Mima H BMC Anesthesiol; 2024 Sep; 24(1):344. PubMed ID: 39342092 [TBL] [Abstract][Full Text] [Related]
13. Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis. Lichtenstern C; Herold C; Mieth M; Brenner T; Decker S; Busch CJ; Hofer S; Zimmermann S; Weigand MA; Bernhard M Mycoses; 2015 Jul; 58(7):399-407. PubMed ID: 26010584 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic Use and Antimicrobial Resistance of Surgical Patients with Peritonitis at a Tertiary Referral Hospital in Rwanda. Rickard J; Ngarambe C; Ndayizeye L; Smart B; Riviello R; Majyambere JP; Ghebre RG Surg Infect (Larchmt); 2018; 19(4):382-387. PubMed ID: 29621001 [TBL] [Abstract][Full Text] [Related]
16. Selective oropharyngeal decontamination versus selective digestive decontamination in critically ill patients: a meta-analysis of randomized controlled trials. Zhao D; Song J; Gao X; Gao F; Wu Y; Lu Y; Hou K Drug Des Devel Ther; 2015; 9():3617-24. PubMed ID: 26203227 [TBL] [Abstract][Full Text] [Related]
17. The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. de Ruiter J; Weel J; Manusama E; Kingma WP; van der Voort PH Infection; 2009 Dec; 37(6):522-7. PubMed ID: 19669089 [TBL] [Abstract][Full Text] [Related]